Muraglitazar

Muraglitazar

CAT N°: 10007853
Price:

514.00 436.90

Muraglitazar is a dual agonist of peroxisome proliferator-activated receptor ? (PPAR?) and PPAR? (EC50s = 0.32 and 0.11 ?M, respectively).{13427} It is selective for PPAR?/? over other nuclear receptors, including PPAR?, RXR?, RARs, estrogen receptor ? (ER?), ER?, androgen receptor (AR), and progesterone receptor (PR). Muraglitazar (50 ?M) reduces the size of lipid droplets in oleic acid-treated HepaRG human hepatocytes.{42456} It reduces plasma levels of glucose, triglycerides, free fatty acids, and insulin by 54, 33, 62, and 48%, respectively, in db/db mice when administered at a dose of 10 mg/kg per day.{13427} Muraglitazar (10 mg/kg per day) reduces plasma levels of glucose, triglycerides, and cholesterol in diet-induced obese mice.{31312} Muraglitazar also inhibits LPS-induced increases in nitric oxide (NO) production and IL-6, TNF-?, and inducible nitric oxide synthase (iNOS) protein levels in J774 murine macrophages in a concentration-dependent manner.{42457} It inhibits carrageenan-induced paw edema in mice when administered at doses ranging from 12.5 to 50 mg/kg.

We also advise you